Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Condylomata Acuminata × Vaccination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 3 Warts 1 Recurrence 1 Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Condylomata Acuminata 1 Cervical Cancer Screening 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Trichloroacetic Acid 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Vaccines 2 Papillomavirus Vaccines 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Ethanol 2 nanocurcumin 1 human papillomavirus vaccine, L1 type 16, 18 1 hecolin 1 Zinc 1 Vaccination 1 Surgical Procedures, Operative 1 Podophyllin 1 PRA1 protein, Candida albicans 1 Medical Records 1 Measles-Mumps-Rubella Vaccine 1 Lasers, Gas 1 Imiquimod 1 Hepatitis B Vaccines 1 Electrocoagulation 1 Diathermy 1 Cyclophosphamide 1 Curcumin 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03296397 2018-02-27

CONDYVAC

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown

Condylomata Acuminata, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡